Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Is ONEOK Stock a Buy?
Is ONEOK Stock a Buy?

Midstream company ONEOK (NYSE: OKE) is sending out mixed signals in the face of a material energy industry downturn. With a massive 11% yield, however, it's worth taking the time to parse through

3 Reasons to Buy Canopy Growth Instead of Aurora Cannabis
3 Reasons to Buy Canopy Growth Instead of Aurora Cannabis

Year to date, shares of the two largest companies in the cannabis sector, Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB), have not been performing well. Issues with oversupply in Canada

My Top 5 Portfolio Holdings for the Second Half of 2020
My Top 5 Portfolio Holdings for the Second Half of 2020

To say that 2020 has been a challenging year for Wall Street would be a gross understatement. Thus far, the coronavirus disease 2019 (COVID-19) pandemic has cost more than 20 million people their

Love Dividends? 3 Stocks You Might Want to Buy
Love Dividends? 3 Stocks You Might Want to Buy

Savvy investors have long included dividend stocks in their portfolios as a reliable wealth accumulation tool, and eventually a foundation for steady income in retirement. Unfortunately, several

2 Biotech Stocks That Could Soar in 2020Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
2 Biotech Stocks That Could Soar in 2020

Stocks in the biotechnology sector have outperformed the broader market year to date. Despite the market volatility throughout this year, there are still good prospects in this sector, especially in

Is Iovance Biotherapeutics a Buy?
Is Iovance Biotherapeutics a Buy?

Cell therapies are increasingly being added to drug pipelines across the biopharmaceutical industry, but Iovance Biotherapeutics (NASDAQ: IOVA) was one of the first movers with its

How Avid Bioservices Beat Wall Street Estimates in Q4
How Avid Bioservices Beat Wall Street Estimates in Q4

Like most stocks, Avid Bioservices (NASDAQ: CDMO) plunged earlier this year in the wake of the COVID-19 pandemic. However, the contract development and manufacturing organization (CDMO) has bounced

Should You Throw in the Towel on Intercept Pharmaceuticals After Its Big Setback?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Should You Throw in the Towel on Intercept Pharmaceuticals After Its Big Setback?

Intercept Pharmaceuticals (NASDAQ: ICPT) fully expected approval from the Food and Drug Administration for obeticholic acid (OCA) in treating non-alcoholic steatohepatitis (NASH). CEO Mark Pruzanski

Better Buy: McDonald's vs. Bloomin' BrandsPhoto, wide shot, wide-angle lens,  Online marketplace, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/27d484d8-d1b1-4519-9797-b5dcaa68d4e2.png
Better Buy: McDonald's vs. Bloomin' Brands

When picking stocks to invest in, it pays to focus on high-quality companies over a time frame long enough to let you ignore the noise. Restaurant stocks are typically tough businesses, but I think

Thinking of Claiming Social Security During COVID-19? 4 Things You Need to Know
Thinking of Claiming Social Security During COVID-19? 4 Things You Need to Know

The COVID-19 crisis has upended so many Americans' lives from a financial standpoint, and that includes older workers who are grappling with unemployment and income loss. If the pandemic has caused

3 Things You Need to Know About Index Funds and ETFs
3 Things You Need to Know About Index Funds and ETFs

Those of us who have invested directly in stocks know very well the sense of anxiety that comes along with it. Though we all know the importance of patience and perseverance when it comes to

This Under-the-Radar Stock Is a Better Way to Bet on Coronavirus VaccinesPhoto, wide shot, wide-angle lens,  Cleaning service, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/66ee0081-ae60-418d-bd6e-b521f7433841.png
This Under-the-Radar Stock Is a Better Way to Bet on Coronavirus Vaccines

More than a dozen companies are now in some way involved in the hunt for a vaccine for COVID-19. These include household names, like Merck, and less famous ones, like Dynavax. Considering how

Got $3,000 to Invest? These 3 Stocks Could Make You Rich
Got $3,000 to Invest? These 3 Stocks Could Make You Rich

This is an unprecedented time in human history and a challenging time for investors. After taking part in the longest bull market run in history, investors were whipsawed into the fastest bear

The 3 Marijuana Stocks You'll Want to Own for the Second Half of 2020
The 3 Marijuana Stocks You'll Want to Own for the Second Half of 2020

For years, marijuana stocks were the hottest thing since sliced bread on Wall Street. All it took was the promise of capacity expansion and eventually international aspirations to send cannabis

4 Reasons You Need to Start Investing Today -- Despite the Recession
4 Reasons You Need to Start Investing Today -- Despite the Recession

In case you missed the memo, the U.S. economy is officially in a recession, and with COVID-19 surges popping up across the country, our hopes for a quick recovery are increasingly being dashed. But

Is Boston Beer Stock a Buy?
Is Boston Beer Stock a Buy?

I made a terrible call on Boston Beer (NYSE: SAM) back in November when I said it was trading at an unrealistic price. It was expensive -- but the company has made the right moves to expand its

Got $3,000? Invest It in These 3 No-Brainer Buys
Got $3,000? Invest It in These 3 No-Brainer Buys

There's little question that this has been a challenging year to be an investor. Even long-term investors have had their resolve tested like never before, with the coronavirus disease 2019

Fedex Corp (FDX) Q4 2020 Earnings Call Transcript
Fedex Corp (FDX) Q4 2020 Earnings Call Transcript

Image source: The Motley Fool.

Fedex Corp (NYSE: FDX)Q4 2020 Earnings CallJun 30, 2020, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Is Invesco Mortgage Capital Set to Fall by 33%?Photo, wide shot, wide-angle lens,  Private equity firm, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/6a5872d8-cc25-46f8-b436-bf3db1953908.png
Is Invesco Mortgage Capital Set to Fall by 33%?

Shares of Invesco Mortgage Capital (NYSE: IVR) could be about to lose one-third of their value, if a new evaluation of the company proves accurate. Bank of America (NYSE: BAC) Securities has

Exela Technologies, Inc. (XELA) Q1 2020 Earnings Call Transcript
Exela Technologies, Inc. (XELA) Q1 2020 Earnings Call Transcript

Image source: The Motley Fool.

Exela Technologies, Inc. (NASDAQ: XELA)Q1 2020 Earnings CallJun 30, 2020, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Avid Bioservices, Inc. (CDMO) Q4 2020 Earnings Call Transcript
Avid Bioservices, Inc. (CDMO) Q4 2020 Earnings Call Transcript

Image source: The Motley Fool.

Avid Bioservices, Inc. (NASDAQ: CDMO)Q4 2020 Earnings CallJun 30, 2020, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Shake Shack Reveals Major China Expansion Plans
Shake Shack Reveals Major China Expansion Plans

China is ready for more fast-casual dining establishments. At least, that's what Shake Shack (NYSE: SHAK) is counting on; the company announced in a press release on Tuesday that it is expanding a

Aurora Cannabis Co-Founder and ex-CEO Retires From Board of Directors
Aurora Cannabis Co-Founder and ex-CEO Retires From Board of Directors

A page in Aurora Cannabis's (NYSE: ACB) history is turning. The company announced that co-founder and former CEO Terry Booth relinquished his seat on the board of directors effective this past

Alphabet Raises Monthly YouTubeTV Price by 30% to $64.99
Alphabet Raises Monthly YouTubeTV Price by 30% to $64.99

Subscribers of Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) YouTube TV will have to reach a little deeper into their pockets if they want to keep watching the streaming video service. Effective on

Why Gogo Flew 14% Higher on Tuesday
Why Gogo Flew 14% Higher on Tuesday

Nearly everyone who's visited a U.S. airport has come across the services of Gogo (NASDAQ: GOGO). The company's specialty is in-flight, high speed internet services. On Tuesday, the stock gained